Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Alba Therapeutics
ClinicalTrials.gov Identifier:
NCT00889473
First received: April 27, 2009
Last updated: July 12, 2012
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)